Sec. 38a-542b. Cancer clinical trials: When eligible for coverage. - Connecticut Statutes

State Codes and Statutes

Statutes > Connecticut > Title38a > Chap700c > Sec38a-542b

      Sec. 38a-542b. Cancer clinical trials: When eligible for coverage. In order to be eligible for coverage of routine patient care costs, as defined in section 38a-542d, a cancer clinical trial shall be conducted under the auspices of an independent peer-reviewed protocol that has been reviewed and approved by: (1) One of the National Institutes of Health; or (2) a National Cancer Institute affiliated cooperative group; or (3) the federal Food and Drug Administration as part of an investigational new drug or device exemption; or (4) the federal Department of Defense or Veterans Affairs. Nothing in sections 38a-542a to 38a-542g, inclusive, shall be construed to require coverage for any single institution cancer clinical trial conducted solely under the approval of the institutional review board of an institution, or any trial that is no longer approved by an entity identified in subdivision (1), (2), (3) or (4) of this section.

      (P.A. 01-171, S. 2, 25.)

      History: P.A. 01-171 effective January 1, 2002.

      See Sec. 38a-504b for similar provisions re individual policies.

State Codes and Statutes

Statutes > Connecticut > Title38a > Chap700c > Sec38a-542b

      Sec. 38a-542b. Cancer clinical trials: When eligible for coverage. In order to be eligible for coverage of routine patient care costs, as defined in section 38a-542d, a cancer clinical trial shall be conducted under the auspices of an independent peer-reviewed protocol that has been reviewed and approved by: (1) One of the National Institutes of Health; or (2) a National Cancer Institute affiliated cooperative group; or (3) the federal Food and Drug Administration as part of an investigational new drug or device exemption; or (4) the federal Department of Defense or Veterans Affairs. Nothing in sections 38a-542a to 38a-542g, inclusive, shall be construed to require coverage for any single institution cancer clinical trial conducted solely under the approval of the institutional review board of an institution, or any trial that is no longer approved by an entity identified in subdivision (1), (2), (3) or (4) of this section.

      (P.A. 01-171, S. 2, 25.)

      History: P.A. 01-171 effective January 1, 2002.

      See Sec. 38a-504b for similar provisions re individual policies.

State Codes and Statutes

Back To Homepage

State Codes and Statutes

Statutes > Connecticut > Title38a > Chap700c > Sec38a-542b

      Sec. 38a-542b. Cancer clinical trials: When eligible for coverage. In order to be eligible for coverage of routine patient care costs, as defined in section 38a-542d, a cancer clinical trial shall be conducted under the auspices of an independent peer-reviewed protocol that has been reviewed and approved by: (1) One of the National Institutes of Health; or (2) a National Cancer Institute affiliated cooperative group; or (3) the federal Food and Drug Administration as part of an investigational new drug or device exemption; or (4) the federal Department of Defense or Veterans Affairs. Nothing in sections 38a-542a to 38a-542g, inclusive, shall be construed to require coverage for any single institution cancer clinical trial conducted solely under the approval of the institutional review board of an institution, or any trial that is no longer approved by an entity identified in subdivision (1), (2), (3) or (4) of this section.

      (P.A. 01-171, S. 2, 25.)

      History: P.A. 01-171 effective January 1, 2002.

      See Sec. 38a-504b for similar provisions re individual policies.